
- 472 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Cellular Senescence in Disease
About this book
Winner of the 2023 PROSE award in Biomedicine and Neuroscience!
Research in the field of senescence has boomed recently due to the gradual realization that senescent cells are associated with a significant number of diseases. The genetic or pharmacological elimination of senescent cells can cause widespread benefits and improves outcomes for most of those diseases. Cellular Senescence in Diseases presents an updated review of the role of cellular senescence in multiple pathologies. Focus is given to those diseases where the implication of senescence has been more extensively documented, such as (cancer, lung and liver diseases, diabetes, Neurodegenerative diseases and others).
The Editors recruited a group of worldwide experts in each individual pathology to review the role of cellular senescence in each one of them, aiming at identifying potential therapeutic pathways. The first two chapters provide an overview of the cellular senescence principles. Next, the chapters are divided into specific diseases. Cancer, including premalignant lesions (OIS), Advanced disease (TIS), and Metastasis are covered. The following condition covered is Lund diseases, including IPF, COPD, and Pulmonary Hypertension. Next Liver Diseases are covered, including Fibrosis and Cirrhosis, and Fatty liver disease. Next there is coverage for Kidney implications, including fibrosis and transplantation. Vascular diseases are covered next including infarction and hear fibrosis, and atherosclerosis. Both diabetes types 1 and 2 are covered next. Following chapters cover Obesity, Sarcopenia, and Bone and Cartilage disorders, respectively. Neurodegenerative diseases are covered next, focusing on Alzheimer and Parkinson. The next chapter discusses accumulation of senescent cell in tissues during aging. The two final chapters cover current developments and conclusions.
Cellular Senescence in Diseases is designed for researchers and clinicians with a focus on the cellular mechanisms of diseases. All chapters cover current experimental therapeutic approaches to eliminate or cancel the pathological effects of senescent cells. Pharmaceutical scientists may also benefit from the contents of the book in the exploration of novel therapeutic opportunities.
- 2023 PROSE Awards - Winner: Category: Biomedicine and Neuroscience: Association of American Publishers
- Provides a thorough introduction to Cellular Senescence
- Covers all major pathologies for which cellular senescence has shown evidence of involvement
- Focuses on possible therapeutic pathways
- Edited and authored by worldwide experts
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Cellular Senescence in Disease by Manuel Serrano,Daniel Munoz-Espin in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Cell Biology. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Cover
- Front Matter
- Table of Contents
- Copyright
- Contributors
- Foreword
- List of Illustrations
- List of Tables
- Chapter 1 : Cellular senescence: from old to new testament
- Chapter 2 : Premalignant lesions and cellular senescence
- Chapter 3 : Lung aging and senescence in health and disease
- Chapter 4 : Cell senescence in pulmonary hypertension
- Chapter 5 : Liver diseases fibrosis and cirrhosis
- Chapter 6 : Cellular senescence during aging and chronic liver diseases: mechanisms and therapeutic opportunities
- Chapter 7 : Kidney diseases: fibrosis
- Chapter 8 : Kidney diseases: transplantation
- Chapter 9 : Vascular diseases: atherosclerosis and atherosclerotic cardiovascular diseases
- Chapter 10 : Diabetes: senescence in type 1 diabetes
- Chapter 11 : Senescence in obesity: causes and consequences
- Chapter 12 : A framework for addressing senescent cell burden in the osteoarthritic knee: therapeutics, immune signaling, and the local-systemic interface
- Chapter 13 : Osteoporosis and bone loss
- Chapter 14 : Cellular senescence in neurodegenerative diseases
- Chapter 15 : Cell senescence is a cause of frailty
- Chapter 16 : Senescence as a therapeutic target: current state and future challenges
- Index
- A